China Isotope & Radiation Corporation announced that, recently, the first carrier-free lutetium-177 GMP production line with annual production capacity of 10,000-curie-grade in China and germanium and gallium 68Ge-68Ga generator production line with annual production capacity of 1,000-grade were fully completed and put into operation, marking the realization of the localized and large-scale commercial supply of GMP-grade lutetium-177 and gallium-68 medical nuclides. The successful commissioning of the production lines will effectively alleviate the problem of insufficient supply of domestic lutetium-177 and gallium-68 and the heavy reliance on imports. The lutetium-177 and gallium-68 products of Chengdu Gaotong Isotope Co.

Ltd. (CNGT), have satisfied the requirements of EMA standards in terms of production line design, production technology, quality indicators, equipment and facilities, management system, etc., and have achieved the first echelon level in the world, with obvious international competitive advantages. In the future, CNGT will enter the international market and participate in the international medical nuclide industry chain cycle. At the same time, CNGT can also officially supply two new nuclides, namely curie-level terbium-161 and scandium-47, which have similar decay, biochemical and in-vivo properties with lutetium-177, and also have unique advantages, bringing new opportunities and possibilities for the development of nuclear medicine.